GlassScriptPhysician profile
Jared Wayne Garlick
NPI 1730509613
$27,120.38
in general payments reported to CMS, 2019-2025
31 companies · $6,467 in 2025
The $6,467 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,035 · 2020: $831 · 2021: $3,073 · 2022: $1,978 · 2023: $1,244 · 2024: $7,493 · 2025: $6,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,862 · Consulting Fee: $3,000 · Long Term Medical Supply Or Device Loan: $2,329 · Travel and Lodging: $1,851 · Honoraria: $975 · Education: $100 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,861.88 |
| Consulting Fee | $3,000.00 |
| Long Term Medical Supply Or Device Loan | $2,328.75 |
| Travel and Lodging | $1,851.43 |
| Honoraria | $975.00 |
| Education | $100.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $7,005.51 | 2024-2025 | |
| Allergan, INC. | $3,494.60 | 2019-2021 | |
| Integra Lifesciences Corporation | $2,765.21 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Davol INC. | $2,366.95 | 2022-2025 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $2,107.15 | 2021 | |
| Mentor Worldwide LLC | $1,985.53 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Siltex Round Spectrum, Stratafix |
| Sientra, INC. | $1,307.84 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Abbvie INC. | $1,253.68 | 2023-2025 | |
| Becton, Dickinson and Company | $975.00 | 2025 | |
| Tepha INC | $968.62 | 2019-2020 | |
| Galderma Laboratories, L.P. | $350.13 | 2019-2022 | |
| Stryker Corporation | $299.87 | 2019 | |
| Tela Bio, INC. | $257.38 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solta Medical, A Division of Bausch Health US, LLC | $252.35 | 2019-2025 | |
| Acell, INC. | $246.47 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $246.11 | 2022-2024 | Celleraterx |
| Depuy Synthes Sales INC. | $235.45 | 2019-2020 | |
| Ethicon US, LLC | $155.38 | 2025 | Megadyne, Smartablatetm System Rf Generator, Harmonic |
| Biom'Up Sa | $131.42 | 2019 | |
| Bioventus LLC | $125.42 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $120.09 | 2020 | |
| Coopersurgical, INC. | $113.64 | 2020 | |
| Solventum Corporation | $104.04 | 2025 | Prevena, Activ.A.C. |
| Endo Pharmaceuticals INC. | $52.96 | 2019 | |
| Medline Industries LP | $45.23 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $39.75 | 2025 | |
| Innovation Technologies INC | $33.06 | 2025 | Irrisept |
| Dilon Technologies, INC. | $24.96 | 2024 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $24.77 | 2024 | Exparel, Zilretta, Iovera |
| Revance Therapeutics, INC. | $16.57 | 2024 | Daxxify |
| Eagle Pharmaceuticals, INC. | $15.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Garlick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.